ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BMR.H Bradmer Pharmaceuticals

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type
Bradmer Pharmaceuticals TSXV:BMR.H TSX Venture Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -

Bradmer Pharmaceuticals Inc.: Director Resignation

31/07/2013 10:00pm

Marketwired Canada


Bradmer Pharmaceuticals Inc. (the "Corporation") (TSX VENTURE:BMR.H) announced
today that Perry N. Dellelce has resigned as a director of the Corporation. He
will continue to act as a consultant to the Corporation. The Corporation thanks
Mr. Dellelce for his commitment and significant past contribution to the
Corporation.


NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION PROVIDER (AS THAT TERM IS
DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR
THE ADEQUACY OR ACCURACY OF THIS RELEASE.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Bradmer Pharmaceuticals Inc.
Paul Van Damme
Chief Financial Officer
416.847.6905

1 Year Bradmer Pharmaceuticals Chart

1 Year Bradmer Pharmaceuticals Chart

1 Month Bradmer Pharmaceuticals Chart

1 Month Bradmer Pharmaceuticals Chart